BioStock: Strong growth for Invent Medic in Q2

When Anna Lindström took over as CEO of Invent Medic just under a year ago, the focus was crystal clear – sales should be increased. After a number of new strategic initiatives, growth reached just over 60 per cent in the second quarter of 2022. At the same time, cost savings have started to show effect. The company will continue to look firmly ahead, hoping to present further growth news in the near future.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/08/strong-growth-for-invent-medic-in-q2/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se